Number and rate* of newly reported cases† of chronic Hepatitis C virus infection, by state or jurisdiction — United States, 2021
Source: CDC, National Notifiable Diseases Surveillance System.
* Rates per 100,000 population.
† Reported confirmed cases. For case definition, see Chronic Hepatitis C.
§ California excludes chronic hepatitis C case counts from Los Angeles County (except for the City of Long Beach and the City of Pasadena) and San Diego County, geographic areas which include approximately 32% of California’s total population.
N: Not reportable. The disease or condition was not reportable by law, statue, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.
This table displays the number and rates of newly reported chronic hepatitis C cases during 2021, by state or jurisdiction. Health departments might not have adequate resources for investigating all cases reported in their jurisdiction. During 2021, chronic hepatitis C was not a reportable condition in four states (Indiana, Kentucky, North Carolina, and Texas), and cases were unavailable from four states or jurisdictions (Arizona, District of Columbia, Hawaii, and Rhode Island). Of note, cases of newly reported chronic hepatitis C do not represent all prevalent hepatitis C virus infections, which cannot be captured in the National Notifiable Diseases Surveillance System.
Of the 107,540 newly reported cases of chronic hepatitis C in 2021, the highest rate of newly reported cases of chronic hepatitis C was in West Virginia (151.4 cases per 100,000 population), followed by Tennessee (99.6 cases per 100,000 population), Alabama (84.8 cases per 100,000 population), Louisiana (78.6 cases per 100,000 population), and Arkansas (72.3 cases per 100,000 population).
- Figure 3.1. Number of reported cases of acute hepatitis C virus infection and estimated infections — United States, 2014–2021
- Figure 3.2. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2020–2021
- Figure 3.3. Rates of reported cases of acute hepatitis C virus infection, by state or jurisdiction — United States, 2021
- Figure 3.4. Rates* of reported cases of acute hepatitis C virus infection, by age group — United States, 2006–2021
- Figure 3.5. Rates of reported cases of acute hepatitis C virus infection, by sex — United States, 2006–2021
- Figure 3.6. Rates of reported cases of acute hepatitis C virus infection, by race/ethnicity — United States, 2006–2021
- Figure 3.7. Availability of information on risk behaviors or exposures associated with reported cases of acute hepatitis C virus infection — United States, 2021
- Figure 3.8. Number of newly reported chronic hepatitis C virus infection cases by sex and age — United States, 2021
- Figure 3.9. Rates of death with hepatitis C virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2021
- Table 3.1. Numbers and rates of reported cases† of acute hepatitis C virus infection, by state or jurisdiction — United States, 2017–2021
- Table 3.2. Numbers and rates of reported cases† of acute hepatitis C virus infection, by demographic characteristics — United States, 2017–2021
- Table 3.3. Reported risk behaviors or exposures among reported cases of acute hepatitis C virus infection — United States, 2021
- Table 3.4. Number of newly reported cases of perinatal hepatitis C virus infection, by state or jurisdiction — United States, 2021
- Table 3.5. Number and rate of newly reported cases of chronic hepatitis C virus infection, by state or jurisdiction — United States, 2021
- Table 3.6. Number and rate of newly reported cases of chronic hepatitis C virus infection, by demographic characteristics — United States, 2021
- Table 3.7. Numbers and rates of deaths with hepatitis C listed as a cause of death among residents, by state or jurisdiction — United States, 2017–2021
- Table 3.8. Numbers and rates of deaths with hepatitis C virus infection listed as a cause of death among residents, by demographic characteristics — United States, 2017–2021